ResearcherNingbo UniversityActive in the last 2 years
Xinhua Zhou
Matched on ORCID iD 0000-0002-4219-7134; OpenAlex author ID A5068522192. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Curcumin suppresses pancreatic cancer progression and glycolysis by modulating the circ_0001535/miR-126-5p/HIPK2 axis. Last author DOI 10.1080/1061186x.2026.2646184↗
- Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis. Co-author DOI 10.1007/s12033-023-00874-0↗
- Exosome-transmitted hsa_circ_0012634 suppresses pancreatic ductal adenocarcinoma progression through regulating miR-147b/HIPK2 axis. Last author DOI 10.1080/15384047.2023.2218514↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Luoluo Wang · 3 shared papers, 2023–2026 · strength 0.81
- Paper Curcumin suppresses pancreatic cancer progression and glycolysis by modulating the circ_0001535/miR-126-5p/HIPK2 axis. DOI 10.1080/1061186x.2026.2646184↗
- Paper Exosome-transmitted hsa_circ_0012634 suppresses pancreatic ductal adenocarcinoma progression through regulating miR-147… DOI 10.1080/15384047.2023.2218514↗
- Paper Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis. DOI 10.1007/s12033-023-00874-0↗
- Xiang Wu · 3 shared papers, 2023–2026 · strength 0.81
- Paper Curcumin suppresses pancreatic cancer progression and glycolysis by modulating the circ_0001535/miR-126-5p/HIPK2 axis. DOI 10.1080/1061186x.2026.2646184↗
- Paper Exosome-transmitted hsa_circ_0012634 suppresses pancreatic ductal adenocarcinoma progression through regulating miR-147… DOI 10.1080/15384047.2023.2218514↗
- Paper Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis. DOI 10.1007/s12033-023-00874-0↗
- Hong Li · 1 shared paper, 2024 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.